{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:22:31Z","timestamp":1787030551649,"version":"build-2736575974"},"reference-count":49,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.3892\/mmr.2015.3809","type":"journal-article","created":{"date-parts":[[2015,5,21]],"date-time":"2015-05-21T05:04:19Z","timestamp":1432184659000},"page":"3881-3889","source":"Crossref","is-referenced-by-count":27,"title":["Interleukin-10 gene transfer into insulin-producing \u03b2 cells protects against diabetes in non-obese diabetic mice"],"prefix":"10.3892","volume":"12","author":[{"given":"AIJING","family":"XU","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WEI","family":"ZHU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TANG","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XIUZHEN","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JING","family":"CHENG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CUILING","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PENG","family":"YI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LI","family":"LIU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2015,5,21]]},"reference":[{"key":"key20180108020404_b1-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2174\/187153006776056576","article-title":"Targeting type 1 diabetes before and at the clinical onset of disease","volume":"6","author":"Bekris","year":"2006","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"key20180108020404_b2-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1517\/03009734000000056","article-title":"Beta-cell activity and destruction in type 1 diabetes","volume":"105","author":"Karlsson","year":"2000","journal-title":"Ups J Med Sci"},{"key":"key20180108020404_b3-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/34419","article-title":"Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes","volume":"391","author":"Wilson","year":"1998","journal-title":"Nature"},{"key":"key20180108020404_b4-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2337\/diab.43.5.613","article-title":"Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation?","volume":"43","author":"Rabinovitch","year":"1994","journal-title":"Diabetes"},{"key":"key20180108020404_b5-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0092-8674(00)81106-X","article-title":"Insulin-dependent diabetes mellitus","volume":"85","author":"Tisch","year":"1996","journal-title":"Cell"},{"key":"key20180108020404_b6-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S1074-7613(00)80392-1","article-title":"The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD","volume":"7","author":"Delovitch","year":"1997","journal-title":"Immunity"},{"key":"key20180108020404_b7-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"708","DOI":"10.2337\/diabetes.52.3.708","article-title":"Adeno-associated virus-mediated IL-10 gene therapy inhibits diabetes recurrence in syngeneic islet cell transplantation of NOD mice","volume":"52","author":"Zhang","year":"2003","journal-title":"Diabetes"},{"key":"key20180108020404_b8-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nri2711","article-title":"The regulation of IL-10 production by immune cells","volume":"10","author":"Saraiva","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"key20180108020404_b9-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"key20180108020404_b10-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.4049\/jimmunol.170.3.1383","article-title":"Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses","volume":"170","author":"Ding","year":"2003","journal-title":"J Immunol"},{"key":"key20180108020404_b11-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1089\/hum.1998.9.12-1701","article-title":"Systemic delivery of interleukin 10 by intramuscular injection of expression plasmid DNA prevents autoimmune diabetes in nonobese diabetic mice","volume":"9","author":"Nitta","year":"1998","journal-title":"Hum Gene Ther"},{"key":"key20180108020404_b12-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.4049\/jimmunol.168.12.6479","article-title":"Suppression of autoimmune diabetes by viral IL-10 gene transfer","volume":"168","author":"Yang","year":"2002","journal-title":"J Immunol"},{"key":"key20180108020404_b13-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/39614","article-title":"A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis","volume":"389","author":"Groux","year":"1997","journal-title":"Nature"},{"key":"key20180108020404_b14-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1084\/jem.190.7.995","article-title":"An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation","volume":"190","author":"Asseman","year":"1999","journal-title":"J Exp Med"},{"key":"key20180108020404_b15-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.4049\/jimmunol.166.9.5530","article-title":"IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells","volume":"166","author":"Levings","year":"2001","journal-title":"J Immunol"},{"key":"key20180108020404_b16-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.4049\/jimmunol.171.5.2270","article-title":"Systemic overexpression of IL-10 induces CD4+CD25+cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion","volume":"171","author":"Goudy","year":"2003","journal-title":"J Immunol"},{"key":"key20180108020404_b17-mmr-12-03-3881","first-page":"1711","article-title":"Effects of adenovirus-mediated interleukin-10 gene transfer on apoptosis and insulin secretion function of beta cell","volume":"90","author":"Xu","year":"2010","journal-title":"Chinese Medical Journal"},{"key":"key20180108020404_b18-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11010-010-0539-x","article-title":"Recombinant adenoviral expression of IL-10 protects beta cell from impairment induced by pro-inflammatory cytokine","volume":"344","author":"Xu","year":"2010","journal-title":"Mol Cell Biochem"},{"key":"key20180108020404_b19-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.1210\/jcem.86.10.7938","article-title":"Th2 cytokines have a partial, direct protective effect on the function and survival of isolated human islets exposed to combined proinflammatory and Th1 cytokines","volume":"86","author":"Marselli","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180108020404_b20-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.2337\/db06-0328","article-title":"Expression of IGF-I in pancreatic islets prevents lymphocytic infiltration and protects mice from type 1 diabetes","volume":"55","author":"Casellas","year":"2006","journal-title":"Diabetes"},{"key":"key20180108020404_b21-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1152\/physrev.00003.2010","article-title":"Type 1 diabetes: Etiology, immunology, and therapeutic strategies","volume":"91","author":"van Belle","year":"2011","journal-title":"Physiol Rev"},{"key":"key20180108020404_b22-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1749-6632.2012.06797.x","article-title":"Proinflammatory cytokines contribute to development and function of regulatory T cells in type 1 diabetes","volume":"1283","author":"Thomas","year":"2013","journal-title":"Ann NY Acad Sci"},{"key":"key20180108020404_b23-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.4049\/jimmunol.166.2.1352","article-title":"Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation","volume":"166","author":"Serreze","year":"2001","journal-title":"J Immunol"},{"key":"key20180108020404_b24-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1124\/pr.55.2.4","article-title":"Interleukin-10 therapy \u2013 review of a new approach","volume":"55","author":"Asadullah","year":"2003","journal-title":"Pharmacol Rev"},{"key":"key20180108020404_b25-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/clin.1994.1068","article-title":"Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse","volume":"71","author":"Pennline","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"key":"key20180108020404_b26-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"13913","DOI":"10.1073\/pnas.251532298","article-title":"Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice","volume":"98","author":"Goudy","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108020404_b27-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.4049\/jimmunol.166.7.4481","article-title":"IFN-gamma\/TNF-alpha synergism as the final effector in autoimmune diabetes: a key role for STAT1\/IFN regulatory factor-1 pathway in pancreatic beta cell death","volume":"166","author":"Suk","year":"2001","journal-title":"J Immunol"},{"key":"key20180108020404_b28-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.4049\/jimmunol.171.7.3348","article-title":"Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells","volume":"171","author":"Tang","year":"2003","journal-title":"J Immunol"},{"key":"key20180108020404_b29-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1084\/jem.20051409","article-title":"Where CD4+CD25+ Treg cells impinge on autoimmune diabetes","volume":"202","author":"Chen","year":"2005","journal-title":"J Exp Med"},{"key":"key20180108020404_b30-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.immuni.2009.08.023","article-title":"How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets","volume":"31","author":"Feuerer","year":"2009","journal-title":"Immunity"},{"key":"key20180108020404_b31-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20040179","article-title":"CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion","volume":"199","author":"Herman","year":"2004","journal-title":"J Exp Med"},{"key":"key20180108020404_b32-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.4049\/jimmunol.171.8.4040","article-title":"Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development","volume":"171","author":"Gregori","year":"2003","journal-title":"J Immunol"},{"key":"key20180108020404_b33-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1074-7613(00)80195-8","article-title":"B7\/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes","volume":"12","author":"Salomon","year":"2000","journal-title":"Immunity"},{"key":"key20180108020404_b34-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1517\/14712598.8.11.1691","article-title":"Natural Treg in autoimmune diabetes: all present and correct?","volume":"8","author":"Walker","year":"2008","journal-title":"Expert Opin Biol Ther"},{"key":"key20180108020404_b35-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.4049\/jimmunol.169.5.2461","article-title":"The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7","volume":"169","author":"Szanya","year":"2002","journal-title":"J Immunol"},{"key":"key20180108020404_b36-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1043-2760(99)00210-6","article-title":"The beta cell in autoimmune diabetes: many mechanisms and pathways of loss","volume":"11","author":"Kay","year":"2000","journal-title":"Trends Endocrinol Metab"},{"issue":"Suppl 2","key":"key20180108020404_b37-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.2337\/diabetes.54.suppl_2.S97","article-title":"Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities","volume":"54","author":"Cnop","year":"2005","journal-title":"Diabetes"},{"key":"key20180108020404_b38-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1126\/science.7761837","article-title":"T helper cell subsets in insulin-dependent diabetes","volume":"268","author":"Katz","year":"1995","journal-title":"Science"},{"key":"key20180108020404_b39-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1073\/pnas.94.1.213","article-title":"Beta cell apoptosis in T cell-mediated autoimmune diabetes","volume":"94","author":"Kurrer","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108020404_b40-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/(SICI)1521-4141(199902)29:02<455::AID-IMMU455>3.0.CO;2-A","article-title":"Apoptosis of pancreatic beta-cells detected in accelerated diabetes of NOD mice: no role of Fas-Fas ligand interaction in autoimmune diabetes","volume":"29","author":"Kim","year":"1999","journal-title":"Eur J Immunol"},{"key":"key20180108020404_b41-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1007\/s001250100021","article-title":"A choice of death \u2013 the signal-transduction of immune-mediated beta-cell apoptosis","volume":"44","author":"Eizirik","year":"2001","journal-title":"Diabetologia"},{"key":"key20180108020404_b42-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/sj.cdd.4400601","article-title":"Serial killers: ordering caspase activation events in apoptosis","volume":"6","author":"Slee","year":"1999","journal-title":"Cell Death Differ"},{"key":"key20180108020404_b43-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"30651","DOI":"10.1074\/jbc.274.43.30651","article-title":"Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45\/inhibitor of caspase-activated DNase inactivation","volume":"274","author":"Wolf","year":"1999","journal-title":"J Biol Chem"},{"key":"key20180108020404_b44-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2337\/diabetes.47.5.727","article-title":"Human islets of Langerhans express Fas ligand and undergo apoptosis in response to interleukin-1beta and Fas ligation","volume":"47","author":"Loweth","year":"1998","journal-title":"Diabetes"},{"key":"key20180108020404_b45-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10495-006-3558-z","article-title":"1, 25-Dihydroxyvitamin D3 protects human pancreatic islets against cytokine-induced apoptosis via down-regulation of the Fas receptor","volume":"11","author":"Riachy","year":"2006","journal-title":"Apoptosis"},{"key":"key20180108020404_b46-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.4049\/jimmunol.167.8.4436","article-title":"IL-10 inhibits apoptosis of promyeloid cells by activating insulin receptor substrate-2 and phosphatidylinositol 3\u2032-kinase","volume":"167","author":"Zhou","year":"2001","journal-title":"J Immunol"},{"key":"key20180108020404_b47-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/cvr\/cvp040","article-title":"IL-10 attenuates TNF-alpha-induced NF kappaB pathway activation and cardiomyocyte apoptosis","volume":"82","author":"Dhingra","year":"2009","journal-title":"Cardiovasc Res"},{"key":"key20180108020404_b48-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"7176","DOI":"10.4049\/jimmunol.1100060","article-title":"IL-10 Prevents apoptosis of brain endothelium during bacteremia","volume":"186","author":"Londo\u00f1o","year":"2011","journal-title":"J Immunol"},{"key":"key20180108020404_b49-mmr-12-03-3881","doi-asserted-by":"crossref","first-page":"G820","DOI":"10.1152\/ajpgi.00438.2005","article-title":"IL-10 protects mouse intestinal epithelial cells from Fas-induced apoptosis via modulating Fas expression and altering caspase-8 and FLIP expression","volume":"291","author":"Bharhani","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2015.3809\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T23:04:26Z","timestamp":1515366266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2015.3809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,21]]},"references-count":49,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,5,21]]},"published-print":{"date-parts":[[2015,9]]}},"alternative-id":["10.3892\/mmr.2015.3809"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2015.3809","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,21]]}}}